Quantcast

PENNSYLVANIA RECORD

Sunday, April 28, 2024

Case activity for Victoria Duncan vs Coopersurgical Inc. on Oct. 5

Filings

The U.S. District Court for the Eastern District of Pennsylvania reported the following activities in the suit brought by Victoria Duncan against Coopersurgical Inc., Duramed Pharmaceuticals Inc. a Division of Barr Pharmaceuticals, INC., D B a Teva Women's Health, INC., THE Cooper Companies Inc., Teva Pharmaceuticals USA Inc., Teva Women's Health Inc. Individually, and and Teva Women's Health LLC, Individually and on Oct. 5.

'Notice Of Removal By The Cooper Companies, Inc, Teva Women's Health, Inc. Individually, And As Successor In Interest To Duramed Pharmaceuticals, Inc., A Divison Of Barr Pharmaceuticals, Inc., Duramed Pharmaceuticals, Inc. A Division Of Barr Pharmaceuticals, Inc., D/b/a Teva Women's Health, Inc., Teva Women's Health, Llc, Individually And As Successor In Interest To Teva's Women's Health, Inc., Coopersurgical, Inc., Teva Pharmaceuticals Usa, Inc, Teva Women's Health Llc F/k/a Teva Women's Health, Inc. (filing Fee $ 400 Receipt Number 0313-14613576), Filed By The Cooper Companies, Inc, Teva Women's Health, Inc. Individually, And As Successor In Interest To Duramed Pharmaceuticals, Inc., A Divison Of Barr Pharmaceuticals, Inc., Duramed Pharmaceuticals, Inc. A Division Of Barr Pharmaceuticals, Inc., D/b/a Teva Women's Health, Inc., Teva Women's Health, Llc, Individually And As Successor In Interest To Teva's Women's Health, Inc., Coopersurgical, Inc., Teva Pharmaceuticals Usa, Inc, Teva Women's Health Llc F/k/A Teva Women's Health, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Vanguard Group, Inc. By The Cooper Companies, Inc.(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including The Cooper Companies, Inc. By Coopersurgical, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceuticals Industries Ltd. By Teva Pharmaceuticals Usa, Inc.(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceuticals Industries Ltd. By Teva Women's Health, Inc. Individually, And As Successor In Interest To Duramed Pharmaceuticals, Inc., A Divison Of Barr Pharmaceuticals, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceuticals Industries Ltd. By Teva Women's Health Llc F/k/A Teva Women's Health, Inc..(rubenstein, Brian)'

'Answer To Complaint By Teva Women's Health Llc F/k/A Teva Women's Health, Inc..(rubenstein, Brian)'

'Answer To Complaint By Teva Women's Health, Inc. Individually, And As Successor In Interest To Duramed Pharmaceuticals, Inc., A Divison Of Barr Pharmaceuticals, Inc..(rubenstein, Brian)'

Case number 2:20-cv-04902 was filed in the U.S. District Court for the Eastern District of Pennsylvania on Oct. 5.

More News